MedPath
HSA Approval

DUPHALAC SYRUP

SIN02818P

DUPHALAC SYRUP

DUPHALAC SYRUP

May 18, 1989

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Licence HolderABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

A06AD11

lactulose

Manufacturer Information

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

ABBOTT BIOLOGICALS B V

Active Ingredients

LACTULOSE

67 g/100 ml

Lactulose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DUPHALAC SYRUP - HSA Approval | MedPath